Streamlined pharmaceutical workflows for precision and innovation
Leverage Labman’s cutting-edge automation to transform your pharmaceutical operations. Integrate our advanced technologies to enhance efficiency, precision, compliance, and scalability, empowering your teams to deliver high-quality products and drive innovation.Key services
Transform your pharmaceuticals lab processes with Labman’s advanced technological solutions.Optimising the pharmaceutical R&D process for speed and precision
Labman’s comprehensive suite of pharmaceutical automation solutions supports every phase of drug development. From initial compound discovery to clinical trials and large-scale manufacturing, our systems streamline workflows, improve reproducibility, and ensure the highest compliance standards, enabling pharmaceutical companies to focus on innovation.Our Capabilties
Our mission is to enhance scientific pursuits with cutting-edge technology. Cultivating relationships with clients, some spanning over 25 years, emphasizes transparency and trust. Our dedicated team goes beyond transactions, actively engaging with clients for a profound understanding of project intricacies. This personalized approach distinguishes us and forms the foundation for consistently delivering technology that delights and inspires.- Hands-on team that will be your points-of-contact throughout the entire process of working with Labman.
- Mechanical, electrical, electronics and software are all in-house at Labman, so you can always be kept up-to-date with where every component is in the project.
- We keep an open door, so if you want to see your Labman technology at any stage in its development, you're always welcome to vist or to video call for updates.
- We understand the importance of industry compliance with all our custom projects meeting GxP regulation and FDA data integrity standards.
Accelerated discovery timelines, enhanced compound optimisation, and higher throughput for DMTA
Labman’s DMTA workflows streamline the drug discovery process with automated cycles of compound design, synthesis, testing, and analysis. This platform enables rapid, iterative optimization of compounds, supporting a wide range of assays like physicochemical profiling, dose-response testing, and structure-activity relationship (SAR) analysis. The integration of computational tools with experimental validation reduces the time from concept to lead candidate selection.- Fully automated Design, Make, Test, Analyze cycles for high-throughput drug discovery.
- Integration with computational design tools and experimental validation workflows.
- Multi-modal assay platforms for screening, SAR analysis, and physicochemical profiling.
- Comprehensive support for both small molecules and biologics-driven drug discovery.
Automated Synthesis and Reaction Kinetics Optimisation
The synthesis of novel pharma compounds demands speed, precision, and the ability to rapidly iterate. Our automated platforms provide scalable, integrated solutions for high-throughput synthesis, ensuring reproducibility and controlled conditions. By automating every aspect, including reaction monitoring and optimisation, we enable faster lead identification without compromising accuracy. Advanced in-situ monitoring tools give real-time insights into reaction kinetics, facilitating data-driven optimisation.- Fully integrated systems for small-molecule synthesis and biologics workflows.
- Real-time reaction monitoring with advanced PAT tools like Raman spectroscopy and FLIR imaging.
- High-throughput reaction screening platforms capable of testing hundreds of reactions simultaneously.
- In-depth kinetic analysis with automated sampling and precise control of temperature, agitation, and irradiation.
- Accelerated compound optimization, increased reproducibility, and deeper insights into reaction mechanisms.
Analytical and purification automation systems
Purity is critical in pharmaceutical compounds, and Labman’s automated purification platforms ensure high-quality isolation. From HPLC and UPLC to mass spectrometry (LC-MS and MALDI-TOF), our systems incorporate advanced purification and analytical technologies. High-throughput capabilities enable rapid compound isolation and characterisation, while innovative vial imaging tools provide precise analysis of solubility, phase behaviour, and sample integrity, ensuring consistent results.- Automated purification platforms for HPLC, UPLC, and mass spectrometry.
- Advanced vial imaging and analysis for precise quantification of solubility and sample integrity.
- Integration of high-throughput filtration, extraction, and re-suspension modules.
- Real-time in-process analysis for accurate compound characterization.
- Enhanced compound purity, efficient purification workflows, and reproducible results.
Formulation, Stability Testing, and Sample Preparation Automation
Labman’s automated systems streamline formulation and stability testing, critical for preclinical and clinical-phase research. Our systems support high-precision dosing, liquid handling, and homogenization, ensuring accurate formulations. Stability testing platforms monitor temperature, humidity, and photostability to assess formulation robustness. Fully compliant with GMP guidelines, these systems facilitate regulatory adherence while accelerating formulation development.- High-precision dosing, liquid handling, and homogenization for accurate formulations.
- Automated stability testing systems for temperature, humidity, and photostability assessments.
- Fully GMP-compliant systems, ensuring adherence to FDA, EMA, and ICH guidelines.
- Automated vial filling, sealing, and long-term sample storage solutions.
- Accelerated stability testing, robust formulations for clinical trials, and regulatory compliance.
Bioprocessing automation for therapeutic development
Labman’s bioprocess automation systems provide scalability and flexibility, integrating seamlessly into pharma manufacturing operations. Our GMP-compliant, modular skids are designed for biomanufacturing—from protein production to viral inactivation and filtration. They ensure smooth scaling from laboratory to commercial production while maintaining the highest standards of quality and data integrity. Our platforms comply with 21 CFR Part 11, ensuring comprehensive regulatory adherence and traceability.- Modular bioprocessing skids designed for scalability from discovery to manufacturing.
- Full integration of purification processes including chromatography, filtration, and viral inactivation.
- Compliance with GMP and 21 CFR Part 11 regulations for data integrity and traceability.
- Seamless transition from lab-scale development to clinical and commercial-scale production.
- Scalable solutions, improved data integrity, and enhanced flexibility in therapeutic manufacturing.